View this email in your browser ([link removed])
Ending medical-school affirmative action will be a plus for patients
New York Post | August 17, 2023 | Sally C. Pipes
*Featured on RealClearHealth

The US Supreme Court effectively prohibited university admissions officers from giving preferential treatment to applicants based on their race this summer. Many medical-school leaders decried the high court’s ruling.

In fact, there’s evidence affirmative-action policies can harm patients as well as aspiring doctors themselves.

Read here . . . ([link removed])
It's Time to End the PBM Shakedown
Newsmax | Sally Pipes | April 18, 2023

Who says bipartisanship is dead?

In the House and Senate, members of both parties are advancing legislation to check the power of pharmacy benefit managers (PBMs), the self-dealing middlemen in the drug supply chain that inflate Americans’ spending on prescriptions by billions of dollars a year.

By shining a light on PBMs’ questionable business practices, and potentially cracking down on some of their anticompetitive behavior, lawmakers can help patients fill their prescriptions without breaking the bank.

Read more... ([link removed])

------------------------------------------------------------

Cancer Patients Need Private Innovation, Not Gov't Meddling
Newsmax | Sally C. Pipes | August 16, 2023

President Joe Biden just announced a new effort ([link removed]) that he hopes will spur the development of better, more precise cancer surgery technologies. The program is part of his administration’s “Cancer Moonshot ([link removed]) ,” which aims to halve cancer death rates in the United States by 2047.

Ironically, one of the biggest obstacles to achieving that goal might be Biden himself — or more specifically, his policies.
Read more... ([link removed])
[link removed]

============================================================
** Twitter ([link removed])
** Facebook ([link removed])
** YouTube ([link removed])
** LinkedIn ([link removed])
** Website ([link removed])
Copyright © 2022 *Pacific Research Institute*, All rights reserved.
You are receiving this email because you opted in via our website.

Our mailing address is:
P.O. Box 60485 Pasadena, CA 91116

** ([link removed])

Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.